<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Epstein-Barr virus (EBV) latency C promoter drives expression of a family of <z:mp ids='MP_0001799'>viral</z:mp> proteins commonly targeted by CD8 cytotoxic T cells </plain></SENT>
<SENT sid="1" pm="."><plain>These proteins are not generally expressed in African Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and in EBV-associated <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The failure to express these proteins is almost certainly an important factor in the evasion of immunosurveillance by EBV-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In a previous study, we have shown that transcriptional activation of the C promoter is inhibited by methylation of a particular CpG site upstream of the promoter that prevents binding of a cellular protein (CBF2), and we have shown that this and adjacent CpG sites are methylated in a Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line </plain></SENT>
<SENT sid="4" pm="."><plain>In the present study, we show that CpG sites in the CBF2 binding region are predominantly methylated in African Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and in EBV-associated <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, we present the first direct evidence that the C promoter is transcriptionally silent in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, we show a complete absence of methylation in the CBF2 binding region in a case of reversible EBV-associated B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> arising in an immunocompromised patient whose <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> shows C promoter transcriptional activity </plain></SENT>
<SENT sid="7" pm="."><plain>By inhibiting expression of highly antigenic <z:mp ids='MP_0001799'>viral</z:mp> proteins, methylation of transcriptional control sequences may veil the presence of virus in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue from CD8(+) cytotoxic T-cell immune surveillance and thus facilitate <z:mp ids='MP_0001799'>viral</z:mp> <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>